These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18195006)

  • 1. Human major histocompatibility complex (MHC) class I molecules with disulfide traps secure disease-related antigenic peptides and exclude competitor peptides.
    Truscott SM; Wang X; Lybarger L; Biddison WE; McBerry C; Martinko JM; Connolly JM; Linette GP; Fremont DH; Hansen TH; Carreno BM
    J Biol Chem; 2008 Mar; 283(12):7480-90. PubMed ID: 18195006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.
    Kim S; Li L; McMurtrey CP; Hildebrand WH; Weidanz JA; Gillanders WE; Diamond MS; Hansen TH
    J Immunol; 2010 Apr; 184(8):4423-30. PubMed ID: 20212098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA fusion vaccines induce epitope-specific cytotoxic CD8(+) T cells against human leukemia-associated minor histocompatibility antigens.
    Rice J; Dunn S; Piper K; Buchan SL; Moss PA; Stevenson FK
    Cancer Res; 2006 May; 66(10):5436-42. PubMed ID: 16707472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.
    Li L; Herndon JM; Truscott SM; Hansen TH; Fleming TP; Goedegebuure P; Gillanders WE
    Vaccine; 2010 Feb; 28(8):1911-8. PubMed ID: 20188246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA fusion gene vaccines induce cytotoxic T-cell attack on naturally processed peptides of human prostate-specific membrane antigen.
    Vittes GE; Harden EL; Ottensmeier CH; Rice J; Stevenson FK
    Eur J Immunol; 2011 Aug; 41(8):2447-56. PubMed ID: 21604260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disulfide bond engineering to trap peptides in the MHC class I binding groove.
    Truscott SM; Lybarger L; Martinko JM; Mitaksov VE; Kranz DM; Connolly JM; Fremont DH; Hansen TH
    J Immunol; 2007 May; 178(10):6280-9. PubMed ID: 17475856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the murine H-2D(b) and human HLA-A*0201 MHC class I-restricted HPV6 E7-specific cytotoxic T lymphocyte epitopes.
    Peng S; Mattox A; Best SR; Barbu AM; Burns JA; Akpeng B; Jeang J; Yang B; Ishida E; Hung CF; Wu TC; Pai SI
    Cancer Immunol Immunother; 2016 Mar; 65(3):261-71. PubMed ID: 26759151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes.
    Dadaglio G; Morel S; Bauche C; Moukrim Z; Lemonnier FA; Van Den Eynde BJ; Ladant D; Leclerc C
    Int Immunol; 2003 Dec; 15(12):1423-30. PubMed ID: 14645151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.
    Chentoufi AA; Zhang X; Lamberth K; Dasgupta G; Bettahi I; Nguyen A; Wu M; Zhu X; Mohebbi A; Buus S; Wechsler SL; Nesburn AB; BenMohamed L
    J Immunol; 2008 Jan; 180(1):426-37. PubMed ID: 18097044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of adipophilin-specific cytotoxic T lymphocytes using a novel HLA-A2-binding peptide that mediates tumor cell lysis.
    Schmidt SM; Schag K; Müller MR; Weinschenk T; Appel S; Schoor O; Weck MM; Grünebach F; Kanz L; Stevanovic S; Rammensee HG; Brossart P
    Cancer Res; 2004 Feb; 64(3):1164-70. PubMed ID: 14871853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
    Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
    J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes.
    He XH; Xu LH; Liu Y
    World J Gastroenterol; 2005 Jul; 11(27):4180-7. PubMed ID: 16015686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
    Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of antigen presentation on TCR modulation and cytokine release: implications for detection and sorting of antigen-specific CD8+ T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes.
    Jäger E; Salter R; Castelli C; Höhn H; Freitag K; Karbach J; Neukirch C; Necker A; Knuth A; Maeurer MJ
    J Immunol; 2002 Mar; 168(6):2766-72. PubMed ID: 11884444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of bioactive chimeric MHC class I tetramer by expression and purification of human-murine chimeric MHC heavy chain and beta(2)m as a fusion protein in Escherichia coli.
    Ren D; Wang F; He X; Jiang L; Li D; Ying H; Sun S
    Protein Expr Purif; 2006 Dec; 50(2):171-8. PubMed ID: 17046278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of immunodominant anti-Gag p17 (SL9) responses among Gag CTL-positive, HIV-uninfected vaccine recipients expressing the HLA-A*0201 allele.
    Ferrari G; Neal W; Ottinger J; Jones AM; Edwards BH; Goepfert P; Betts MR; Koup RA; Buchbinder S; McElrath MJ; Tartaglia J; Weinhold KJ
    J Immunol; 2004 Aug; 173(3):2126-33. PubMed ID: 15265949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved generation of HLA class I/peptide tetramers.
    Sato Y; Sahara H; Tsukahara T; Kondo M; Hirohashi Y; Nabeta Y; Kawaguchi S; Ikeda H; Torigoe T; Ichimiya S; Tamura Y; Wada T; Yamashita T; Goto M; Takasu H; Sato N
    J Immunol Methods; 2002 Dec; 271(1-2):177-84. PubMed ID: 12445740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein.
    Street MD; Doan T; Herd KA; Tindle RW
    Immunology; 2002 Aug; 106(4):526-36. PubMed ID: 12153516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.